January 19, 2005 General News

ACADIA Pharmaceuticals to Present at the Piper Jaffray 17th Annual Health Care Conference on January 26, 2005

SAN DIEGO, Jan. 19 /PRNewswire-FirstCall/ — ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that Uli Hacksell, Ph.D., Chief Executive Officer, will present at the Piper Jaffray 17th Annual Health Care Conference on January 26, 2005, at 3:30 pm Eastern Time at The Pierre Hotel in New York City.

A live webcast of ACADIA’s presentation will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website through February 9, 2005.

About ACADIA Pharmaceuticals

ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA currently has four drug programs in clinical development as well as a portfolio of preclinical and discovery assets directed at large unmet medical needs, including schizophrenia, Parkinson’s disease, neuropathic pain, and glaucoma. Using its proprietary drug discovery platform, ACADIA has discovered all of the drug candidates in its product pipeline. ACADIA’s corporate headquarters and biology research facilities are located in San Diego, California and its chemistry research facilities are located near Copenhagen, Denmark.

ACADIA Pharmaceuticals Inc.
Thomas H. Aasen, Vice President and Chief Financial Officer
Lisa Barthelemy, Director of Investor Relations
+1 858-558-2871

Web site: http://www.acadia-pharm.com

Media Contact

Investor Contact